AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in ...

Sep. 22, 2024 — Researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney disease than standard laboratory blood ...

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...

Our bodies have several vital organs that quietly toil away to keep us functioning properly. Among these are the kidneys, two fist-sized organs that sit on either side of the spine below the ribs.

EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

Although that may hold true in most cases, when it comes to kidney disease and injury, physicians are advised to never keep “zebras” too far from their mind. “When I was in training ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is not sterile and low ...